Long Term Outcome of Intravitreal Ranibizumab for ROP

Status Completed

Clinical Trial Summary

premature infants who had a history of intravitreal injection of (Ranibizumab) not less than one year were examined for refractive state and biometry

Clinical Trial Description

Medical records were collected in each group for birth history data, including gestational age (GA), birth weight (BW), and postmenstrual age (PMA) at time of intravitreal injection. The zone and stage of ROP were also recorded. All patients were evaluated for refractive errors and cycloplegic refraction was performed using a handheld auto keratorefractometer (Righton Retinomax K-plus2), and confirmed by retinoscopy examination. Refractive errors were calculated as spherical equivalent and astigmatism in cylinder. The average corneal radius of curvature was measured by handheld auto kerato-refractometer (Righton Retinomax K-plus2). The biometric optic components, including anterior chamber depth, lens thickness, and axial length, were measured using A-scan ultrasound (model Echoscan US-4000 / 500; Nidek) ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04537065
Study type	Observational
Source	Mansoura University
Contact
Status	Completed
Phase
Start date	April 1, 2018
Completion date	September 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05043077` - Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening	Phase 4
Completed	`NCT04838665` - Changes in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomized Double Blind Clinical Study	Phase 4
Completed	`NCT04408807` - Stress Induced by Screening for Retinopathy of Prematurity - Should Speculum and Indentation Rather be Avoided	N/A
Recruiting	`NCT03083431` - Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity	Phase 2
Enrolling by invitation	`NCT04985448` - Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data
Recruiting	`NCT02090322` - Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1	N/A
Completed	`NCT00872664` - Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids	N/A
Unknown status	`NCT00254176` - Cysteine Supplementation in Critically Ill Neonates	Phase 2/Phase 3
Completed	`NCT06452524` - Prematurity and Ophthalmological Changes
Completed	`NCT04101721` - Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity	Phase 3
Enrolling by invitation	`NCT02050971` - Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates	Phase 1
Terminated	`NCT01335113` - A Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity
Active, not recruiting	`NCT00027222` - The Early Treatment for Retinopathy of Prematurity Study (ETROP)	Phase 2/Phase 3
Recruiting	`NCT06109285` - Validation of i-ROP DL to Detect More Than Mild ROP	N/A
Completed	`NCT02014454` - Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature	Phase 2
Completed	`NCT01861470` - REDEXAM - Reducing Painful Eye Examinations in Preterm Infants	N/A
Terminated	`NCT00634972` - Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity	Phase 4
Completed	`NCT05701124` - Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity	Phase 3
Completed	`NCT04092127` - Pain of Premature Babies and RetCam (DOLICAM)
Completed	`NCT04621136` - PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity	Phase 1/Phase 2